Ventricular Tachycardia, Catecholaminergic Polymorphic, 2 (CPVT2)

Ventricular Tachycardia, Catecholaminergic Polymorphic, 2(来自ICD-11)
别称:
Catecholaminergic Polymorphic Ventricular Tachycardia 2
Stress-Induced Polymorphic Ventricular Tachycardia
Bidirectional Tachycardia
Vtsip
Cpvt2
Tachycardia, Ventricular, Catecholaminergic Polymorphic, Type 2
Ventricular Tachycardia, Catecholaminergic Polymorphic, 1
Ventricular Tachycardia, Stress-Induced Polymorphic
Malignant Paroxysmal Ventricular Tachycardia
Double Tachycardia Induced by Catecholamines
Paroxysmal Familial Ventricular Fibrillation
Multifocal Ventricular Premature Beats
Multifocal Premature Ventricular Beats
Paroxysmal Ventricular Fibrillation
Syncopal Paroxysmal Tachycardia
Syncopal Tachyarythmia
Multifocal Pvcs
Cvpt2
加入收藏
Basic Information
Medical Symptom
Gene & Mutation
Related Drugs
Disease Model
References Literature
Ventricular Tachycardia, Catecholaminergic Polymorphic, 2, also known as catecholaminergic polymorphic ventricular tachycardia 2, is related to ventricular tachycardia, catecholaminergic polymorphic, 1, with or without atrial dysfunction and/or dilated cardiomyopathy and catecholaminergic polymorphic ventricular tachycardia, and has symptoms including seizures and syncope. An important gene associated with Ventricular Tachycardia, Catecholaminergic Polymorphic, 2 is CASQ2 (Calsequestrin 2), and among its related pathways/superpathways are Beta-Adrenergic Signaling and Dopamine-DARPP32 Feedback onto cAMP Pathway. Affiliated tissues include heart and heart-ventricle, and related phenotypes are syncope and polymorphic ventricular tachycardia
查看原文 参与反馈
相关ID:

基础信息

遗传方式
发病时间
患病率/发病率
相关基因
相关模型
参考文献
MALACARDS
AR
Unknown
--
5
62
6

疾病表征

#
分类
表征
HPO概率
Orphanet概率
HPO来源
暂无相关数据

基因 & 突变

#
基因
作用分类
分值
突变数量
暂无相关数据

靶点药物

药物名称
CAS号
研发状态
临床阶段
暂无相关数据

疾病模型

类型
名称
MGI
相关基因
品系来源
文献数量
暂无相关数据

文献报道

标题
PMID
期刊
年代
IF
暂无数据
Wechat
Comparison
Al agent
Tutorials
Back to top